These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25002530)

  • 1. Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/Bik.
    Chen S; Zhou L; Zhang Y; Leng Y; Pei XY; Lin H; Jones R; Orlowski RZ; Dai Y; Grant S
    Mol Cell Biol; 2014 Sep; 34(18):3435-49. PubMed ID: 25002530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.
    Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B
    Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux.
    Samarasinghe B; Wales CT; Taylor FR; Jacobs AT
    Biochem Pharmacol; 2014 Feb; 87(3):445-55. PubMed ID: 24291777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
    Rui YN; Xu Z; Chen Z; Zhang S
    Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation.
    Zhu H; Guo W; Zhang L; Wu S; Teraishi F; Davis JJ; Dong F; Fang B
    Cancer Biol Ther; 2005 Jul; 4(7):781-6. PubMed ID: 16082182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury.
    Sarkar C; Zhao Z; Aungst S; Sabirzhanov B; Faden AI; Lipinski MM
    Autophagy; 2014; 10(12):2208-22. PubMed ID: 25484084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAG3 and SYNPO (synaptopodin) facilitate phospho-MAPT/Tau degradation via autophagy in neuronal processes.
    Ji C; Tang M; Zeidler C; Höhfeld J; Johnson GV
    Autophagy; 2019 Jul; 15(7):1199-1213. PubMed ID: 30744518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis.
    Chen S; Zhang Y; Zhou L; Leng Y; Lin H; Kmieciak M; Pei XY; Jones R; Orlowski RZ; Dai Y; Grant S
    Blood; 2014 Oct; 124(17):2687-97. PubMed ID: 25208888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells.
    Li C; Li R; Grandis JR; Johnson DE
    Mol Cancer Ther; 2008 Jun; 7(6):1647-55. PubMed ID: 18566236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62.
    Myeku N; Figueiredo-Pereira ME
    J Biol Chem; 2011 Jun; 286(25):22426-40. PubMed ID: 21536669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy protein p62/SQSTM1 is involved in HAMLET-induced cell death by modulating apotosis in U87MG cells.
    Zhang YB; Gong JL; Xing TY; Zheng SP; Ding W
    Cell Death Dis; 2013 Mar; 4(3):e550. PubMed ID: 23519119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells.
    Wang L; Gao C; Yao S; Xie B
    Int J Mol Sci; 2013 Nov; 14(12):23212-30. PubMed ID: 24287900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.
    Nikrad M; Johnson T; Puthalalath H; Coultas L; Adams J; Kraft AS
    Mol Cancer Ther; 2005 Mar; 4(3):443-9. PubMed ID: 15767553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERADication of EDEM1 occurs by selective autophagy and requires deglycosylation by cytoplasmic peptide N-glycanase.
    Park S; Jang I; Zuber C; Lee Y; Cho JW; Matsuo I; Ito Y; Roth J
    Histochem Cell Biol; 2014 Aug; 142(2):153-69. PubMed ID: 24664425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of autophagy on multiple myeloma cell viability.
    Hoang B; Benavides A; Shi Y; Frost P; Lichtenstein A
    Mol Cancer Ther; 2009 Jul; 8(7):1974-84. PubMed ID: 19509276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal arginylation targets endoplasmic reticulum chaperone BiP for autophagy through p62 binding.
    Cha-Molstad H; Sung KS; Hwang J; Kim KA; Yu JE; Yoo YD; Jang JM; Han DH; Molstad M; Kim JG; Lee YJ; Zakrzewska A; Kim SH; Kim ST; Kim SY; Lee HG; Soung NK; Ahn JS; Ciechanover A; Kim BY; Kwon YT
    Nat Cell Biol; 2015 Jul; 17(7):917-29. PubMed ID: 26075355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GX15-070 (obatoclax) induces apoptosis and inhibits cathepsin D- and L-mediated autophagosomal lysis in antiestrogen-resistant breast cancer cells.
    Schwartz-Roberts JL; Shajahan AN; Cook KL; Wärri A; Abu-Asab M; Clarke R
    Mol Cancer Ther; 2013 Apr; 12(4):448-59. PubMed ID: 23395885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy.
    Park JM; Huang S; Wu TT; Foster NR; Sinicrope FA
    Cancer Biol Ther; 2013 Feb; 14(2):100-7. PubMed ID: 23192274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
    Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
    Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).
    Singh K; Sharma A; Mir MC; Drazba JA; Heston WD; Magi-Galluzzi C; Hansel D; Rubin BP; Klein EA; Almasan A
    Mol Cancer; 2014 Mar; 13():70. PubMed ID: 24655592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.